Magnesium for Sleep: What 8 Clinical Trials Actually Show

Magnesium plays a role in over 300 enzymatic reactions, but its relevance to sleep centres on two mechanisms: regulation of GABA receptors (the brain's primary inhibitory neurotransmitter) and modulation of the hypothalamic-pituitary-adrenal (HPA) axis, which governs cortisol release.

A 2012 double-blind, placebo-controlled trial published in the Journal of Research in Medical Sciences studied 46 elderly adults with insomnia. Participants who took 500 mg of magnesium daily for 8 weeks showed statistically significant improvements in sleep time, sleep efficiency, and serum melatonin levels compared to placebo. Their cortisol levels also decreased — a marker of reduced physiological stress.

More recently, a 2023 systematic review and meta-analysis in BMC Complementary Medicine and Therapies pooled data from 3 RCTs totalling 151 older adults. The analysis found that magnesium supplementation was associated with a reduction in sleep onset latency of approximately 17 minutes — a clinically meaningful difference for people who lie awake for 30+ minutes.

Not all magnesium forms are created equal when it comes to sleep. The most studied forms for sleep are:

Magnesium glycinate — Glycine itself has calming properties and acts as an inhibitory neurotransmitter. A 2012 study in Neuropharmacology demonstrated glycine's role in lowering core body temperature, which is a physiological trigger for sleep onset. Magnesium glycinate combines magnesium's GABAergic effects with glycine's independent sleep benefits.

Magnesium citrate — Highly bioavailable (absorbed well), but primarily studied for bowel regularity rather than sleep specifically. Still, its high absorption rate means more magnesium reaches systemic circulation.

Magnesium oxide — Cheap but poorly absorbed (only ~4% bioavailability per a 2001 study in Journal of the American College of Nutrition). Most of the clinical sleep trials used glycinate or citrate forms.

Magnesium threonate (Magtein) — The only form shown to cross the blood-brain barrier efficiently in preclinical models (published in Neuron, 2010). Human data is still limited, but early results for cognitive function are promising.

For sleep specifically, magnesium glycinate at 200–400 mg elemental magnesium is the best-supported option.

Most clinical trials used 250–500 mg of elemental magnesium taken 30–60 minutes before bed. The Australian RDI for magnesium is 400–420 mg/day for men and 310–320 mg/day for women — but most Australians fall short of this through diet alone.

Key considerations:

• •Start with 200 mg to assess tolerance (higher doses can cause loose stools)
• •Take with food to improve absorption and reduce GI effects
• •Effects typically build over 1–4 weeks; this isn't a next-day fix
• •Avoid magnesium oxide if your primary goal is sleep — opt for glycinate or citrate

Magnesium is generally well-tolerated, but interactions exist:

• •Antibiotics (tetracyclines, fluoroquinolones): Magnesium can bind to these drugs and reduce their absorption. Separate doses by at least 2 hours.
• •Bisphosphonates (for osteoporosis): Same binding concern — take magnesium at a different time of day.
• •Kidney disease: Impaired magnesium clearance can lead to dangerous hypermagnesemia. Consult your doctor.
• •Blood pressure medications: Magnesium can enhance hypotensive effects.

The evidence for magnesium improving sleep quality is moderate and growing. It's strongest for older adults with low magnesium levels, but broader population studies are still needed. Magnesium glycinate at 200–400 mg before bed is a reasonable, low-risk intervention — especially if you suspect dietary insufficiency.

It won't knock you out like a pharmaceutical sleep aid, but it addresses an underlying nutritional gap that many Australians have. Think of it as setting the stage for better sleep rather than forcing it.